251 related articles for article (PubMed ID: 19324051)
1. Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain.
Pak JE; Sharon C; Satkunarajah M; Auperin TC; Cameron CM; Kelvin DJ; Seetharaman J; Cochrane A; Plummer FA; Berry JD; Rini JM
J Mol Biol; 2009 May; 388(4):815-23. PubMed ID: 19324051
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.
Berry JD; Hay K; Rini JM; Yu M; Wang L; Plummer FA; Corbett CR; Andonov A
MAbs; 2010; 2(1):53-66. PubMed ID: 20168090
[TBL] [Abstract][Full Text] [Related]
3. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
4. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
[TBL] [Abstract][Full Text] [Related]
5. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
Li F; Li W; Farzan M; Harrison SC
Science; 2005 Sep; 309(5742):1864-8. PubMed ID: 16166518
[TBL] [Abstract][Full Text] [Related]
6. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity.
He Y; Li J; Jiang S
Biochem Biophys Res Commun; 2006 May; 344(1):106-13. PubMed ID: 16615996
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
Li F
J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
Hwang WC; Lin Y; Santelli E; Sui J; Jaroszewski L; Stec B; Farzan M; Marasco WA; Liddington RC
J Biol Chem; 2006 Nov; 281(45):34610-6. PubMed ID: 16954221
[TBL] [Abstract][Full Text] [Related]
10. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
He Y; Li J; Heck S; Lustigman S; Jiang S
J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
[TBL] [Abstract][Full Text] [Related]
11. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
13. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
[TBL] [Abstract][Full Text] [Related]
14. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
[TBL] [Abstract][Full Text] [Related]
16. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.
Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C
Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741
[TBL] [Abstract][Full Text] [Related]
17. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
[TBL] [Abstract][Full Text] [Related]
18. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
[TBL] [Abstract][Full Text] [Related]
19. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.
He Y; Zhou Y; Siddiqui P; Jiang S
Biochem Biophys Res Commun; 2004 Dec; 325(2):445-52. PubMed ID: 15530413
[TBL] [Abstract][Full Text] [Related]
20. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
Yi CE; Ba L; Zhang L; Ho DD; Chen Z
J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
